Telomeres and Alzheimers Disease

Can Telomeres Support help with Alzheimers Disease?

What is Alzheimer’s disease

Alzheimer’s disease (AD) is the most common form of dementia.

Dementia is the loss of cognitive functioning—thinking, remembering, and reasoning—and behavioral abilities, to such an extent that it interferes with a person’s daily life and activities.

Dementia ranges in severity from the mildest stage, when it is just beginning to affect a person’s functioning, to the most severe stage, when the person must depend completely on others for basic activities of daily living.

There is no cure for the disease, which worsens as it progresses, and eventually leads to death

Most often, AD is diagnosed in people over 65 years of age, although the less-prevalent early-onset Alzheimer’s can occur much earlier.

In 2006, there were 26.6 million sufferers worldwide. Alzheimer’s is predicted to affect 1 in 85 people globally by 2050.

As the disease advances, symptoms can include confusion, irritability and aggression, mood swings, trouble with language, and long-term memory loss. As the sufferer declines they often withdraw from family and society.Gradually, bodily functions are lost, ultimately leading to death.

Alzheimer’s disease is characterised by loss of neurons and synapses in the cerebral cortex and certain subcortical regions. This loss results in gross atrophy of the affected regions, including degeneration in the temporal lobe and parietal lobe, and parts of the frontal cortex and cingulate gyrus.

Studies using MRI and PET have documented reductions in the size of specific brain regions in people with AD as they progressed from mild cognitive impairment to Alzheimer’s disease, and in comparison with similar images from healthy older adults

Currently there are about 280,000 Australians living with dementia. Experts suggest that as many as 5.1 million Americans may have Alzheimer’s disease.

Research Papers on Telomere shortening and Alzheimers Disease

Scientific papers have been published which state that :

Telomere shortening correlates with Alzheimer’s disease status.  ( Click Here for original article )

Alzheimer’s is one of the conditions that are associated with short Telomeres.


Video on Telomere lengthening

Remember what happened in Dr DePinho’s mice when the Telomeres were lengthened, the brains of the old mice increased from 75% of normal size back to normal size.  View the video here

The fact that Dr De Pinho has shown that ‘Aged Tissues Have a Point of Return’ and the development of Telomerase Activators will prove to be one of the GREATEST MEDICAL BREAKTHROUGHS of all time ! 

Learn how you can order Telomeres support product to help stop telomere shortening Here      

@ 2013 All Rights Reserved
Powered by WordPress.